Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction

Severe early-onset fetal growth restriction (FGR) is an untreatable condition associated with substantial mortality and morbidity for the fetus and neonate. There has been growing interest in novel therapies such as nitric oxide donors and promotors to improve placental function and outcomes for the...

Full description

Bibliographic Details
Main Authors:	Sharp, A, Cornforth, C, Jackson, R, Harrold, J, Turner, MA, Kenny, L, Baker, PN, Johnstone, ED, Khalil, A, von Dadelszen, P, Papageorghiou, AT, Alfirevic, Z
Format:	Journal article
Language:	English
Published:	Elsevier 2019

Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction

Similar Items